Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 11-20 of 102 (Search time: 0.028 seconds).
Issue DateTitleAuthor(s)
2019Cachexia in head and neck squamous cell carcinoma (HNSCC) patients (pts) after cisplatin-based chemoradiation (CRT): A cross-sectional study.CASTRO, Gilberto; NEVES, Willian das; RIVELLI, Thomas Giollo; SIMAO, Eduardo Furquim; MARTINS, Renata Eiras; KULCSAR, Marco Aurelio Vamondes
2019Synchronous esophageal cancer impact on survival of head and neck squamous cell carcinoma (HNSCC) patients.DIVINO, Paulo Henrique Amor; MATOS, Gustavo Duarte Ramos; LIMA, Karolina; CASTRO, Gilberto; MARTA, Gustavo Nader; TAKEDA, Flavio Roberto; CECCONELLO, Ivan; BRAGHIROLI, Oddone Freitas Melro; MAK, Milena Perez
2019The ideal amount of physical activity to improve quality of life and symptoms in lung cancer patients: A systematic review.CASTRO, Gilberto; CODIMA, Alberto; NEVES, Willian das; BORGES, Ana Paula Souza
2019Cancer driver genes in prostate cancer from young men.MAISTRO, Simone; XAVIER, Camila dos Santos; SERIO, Pedro Adolpho M. P.; KATAYAMA, Maria Lucia Hirata; ROELA, Rosimeire Aparecida; FOLGUEIRA, Maria A. A. Koike
2019The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).PAZ-ARES, Luis G.; GARON, Edward B.; ARDIZZONI, Andrea; BARLESI, Fabrice; CHO, Byoung Chul; CASTRO, Gilberto; MARCHI, Pedro De; FELIP, Enriqueta; GOTO, Yasushi; GREYSTOKE, Alastair; LU, Shun; LIM, Darren Wan Teck; PAPADIMITRAKOPOULOU, Vassiliki; RECK, Martin; SOLOMON, Benjamin J.; SPIGEL, David R.; TAN, Daniel Shao-Weng; THOMAS, Michael; YANG, James Chih-Hsin; JOHNSON, Bruce E.
2019Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).RISCHIN, Danny; HARRINGTON, Kevin J.; GREIL, Richard; SOULIERES, Denis; TAHARA, Makoto; CASTRO, Gilberto de; PSYRRI, Amanda; BASTE, Neus; NEUPANE, Prakash C.; BRATLAND, Ase; FUEREDER, Thorsten; HUGHES, Brett Gordon Maxwell; MESIA, Ricard; NGAMPHAIBOON, Nuttapong; RORDORF, Tamara; ISHAK, Wan Zamaniah Wan; ZHANG, Yayan; JIN, Fan; GUMUSCU, Burak; BURTNESS, Barbara
2012Metronomic chemotherapy (MC): Results of two feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC)PETRY, Vanessa; LEAL, Alessandro; ARAI, Roberto J.; PIATO, Jose R.; ANDRADE, Felipe; PAIVA, Marcelo; FERRAZ, Marcio R.; MARINHO, Simone; HOFF, Paulo Marcelo; MANO, Max S.
2012Excision repair cross-complementary group 1 (ERCC1) as a prognostic biomarker in patients (pts) with solid tumors: A meta-analysis on detection methodsMAK, Milena Perez; TAKAHASHI, Tiago Kenji; HOFF, Paulo Marcelo; CASTRO, Gilberto; SNITCOVSKY, Igor M. L.
2012Expression of ERCC1 protein (excision repair cross complementing group 1) in patients with invasive carcinoma of the uterine cervix (CC) undergoing definitive chemoradiation (CR)CAIRES, Inacelli Queiroz de Souza; CAIRES-LIMA, Rafael; COLOMBO, Renata; RAMOS, Clarissa C. A.; MACHADO, Karime Kalil; SIQUEIRA, Sheila Aparecida Coelho; CARVALHO, Heloisa de Andrade; FUKUSHIMA, Julia Tizue; ADRA, Thais Rodrigues; HOFF, Paulo M.; ESTEVEZ-DIZ, Maria Del Pilar
2012Self-reported conflicts of interest (sfCOI) of authors and the interpretation of randomized phase III trials (RCT) and related editorials (REd) in cancer researchBARIANI, Giovanni Mendonca; FERRARI, Anezka Carvalho Rubin De Celis; HOFF, Paulo Marcelo; RIECHELMANN, Rachel